The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing-Reference-Cited by-同舟云学术

The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing

Published:2015-03 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Tesori Valentina,Piscaglia Anna Chiara,Samengo Daniela,Barba Marta,Bernardini Camilla,Scatena Roberto,Pontoglio Alessandro,Castellini Laura,Spelbrink Johannes N.,Maulucci Giuseppe,Puglisi Maria Ausiliatrice,Pani Giovambattista,Gasbarrini Antonio

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep09149.pdf

Reference41 articles.

1. Bonuccelli, G. et al. Ketones and lactate “fuel” tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9, 3506–3514 (2010).

2. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7, 11–20 (2008).

3. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

4. WARBURG, O. On respiratory impairment in cancer cells. Science 124, 269–270 (1956).

5. Pani, G., Giannoni, E., Galeotti, T. & Chiarugi, P. Redox-based escape mechanism from death: the cancer lesson. Antioxid. Redox. Signal. 11, 2791–2806 (2009).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect;Biochemical Pharmacology;2024-09

2. Deciphering the role of non-coding RNAs involved in sorafenib resistance;Heliyon;2024-04

3. Glycolysis maintains AMPK activation in sorafenib-induced Warburg effect;Molecular Metabolism;2023-11

4. Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance;Biochimie;2023-05

5. Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma;Biochimie;2022-11